These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 24498172)
1. Targeting innate receptors with MIS416 reshapes Th responses and suppresses CNS disease in a mouse model of multiple sclerosis. White M; Webster G; O'Sullivan D; Stone S; La Flamme AC PLoS One; 2014; 9(1):e87712. PubMed ID: 24498172 [TBL] [Abstract][Full Text] [Related]
2. Innate IFN-γ ameliorates experimental autoimmune encephalomyelitis and promotes myeloid expansion and PDL-1 expression. White MPJ; Webster G; Leonard F; La Flamme AC Sci Rep; 2018 Jan; 8(1):259. PubMed ID: 29321652 [TBL] [Abstract][Full Text] [Related]
3. First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors. Ishihara M; Tono Y; Miyahara Y; Muraoka D; Harada N; Kageyama S; Sasaki T; Hori Y; Soga N; Uchida K; Shiraishi T; Sato E; Kanda H; Mizuno T; Webster GA; Ikeda H; Katayama N; Sugimura Y; Shiku H Cancer Immunol Immunother; 2020 Apr; 69(4):663-675. PubMed ID: 31980914 [TBL] [Abstract][Full Text] [Related]
4. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination. Rostami A; Ciric B J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791 [TBL] [Abstract][Full Text] [Related]
5. Interferon-γ orchestrates the number and function of Th17 cells in experimental autoimmune encephalomyelitis. Berghmans N; Nuyts A; Uyttenhove C; Van Snick J; Opdenakker G; Heremans H J Interferon Cytokine Res; 2011 Jul; 31(7):575-87. PubMed ID: 21348780 [TBL] [Abstract][Full Text] [Related]
6. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Murphy AC; Lalor SJ; Lynch MA; Mills KH Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983 [TBL] [Abstract][Full Text] [Related]
7. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097 [TBL] [Abstract][Full Text] [Related]
8. Synergistic Targeting of Innate Receptors TLR7 and NOD2 for Therapeutic Intervention in Multiple Sclerosis. Dubik M; Marczynska-Grzelak J; Sørensen MZ; Dieu RS; Rusin D; Schiöth ES; Ramazani B; Belal R; Ojha B; Krieger J; Arengoth DS; Wlodarczyk A; Owens T; Khorooshi R Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000569 [TBL] [Abstract][Full Text] [Related]
9. Inflammation in the central nervous system and Th17 responses are inhibited by IFN-gamma-Induced IL-18 binding protein. Millward JM; Løbner M; Wheeler RD; Owens T J Immunol; 2010 Aug; 185(4):2458-66. PubMed ID: 20644165 [TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 9-dependent interferon production prevents group 2 innate lymphoid cell-driven airway hyperreactivity. Thio CL; Lai AC; Chi PY; Webster G; Chang YJ J Allergy Clin Immunol; 2019 Sep; 144(3):682-697.e9. PubMed ID: 30914379 [TBL] [Abstract][Full Text] [Related]
11. Innate signaling within the central nervous system recruits protective neutrophils. Khorooshi R; Marczynska J; Dieu RS; Wais V; Hansen CR; Kavan S; Thomassen M; Burton M; Kruse T; Webster GA; Owens T Acta Neuropathol Commun; 2020 Jan; 8(1):2. PubMed ID: 31915070 [TBL] [Abstract][Full Text] [Related]
12. Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis. Trager N; Smith A; Wallace Iv G; Azuma M; Inoue J; Beeson C; Haque A; Banik NL J Neurochem; 2014 Jul; 130(2):268-79. PubMed ID: 24447070 [TBL] [Abstract][Full Text] [Related]
13. Mycobacterium bovis bacille Calmette-Guérin infection in the CNS suppresses experimental autoimmune encephalomyelitis and Th17 responses in an IFN-gamma-independent manner. Lee J; Reinke EK; Zozulya AL; Sandor M; Fabry Z J Immunol; 2008 Nov; 181(9):6201-12. PubMed ID: 18941210 [TBL] [Abstract][Full Text] [Related]
14. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response. Zheng X; Hu X; Zhou G; Lu Z; Qiu W; Bao J; Dai Y J Neuroimmunol; 2008 Feb; 194(1-2):107-14. PubMed ID: 18207251 [TBL] [Abstract][Full Text] [Related]
15. Multiple functional therapeutic effects of TnP: A small stable synthetic peptide derived from fish venom in a mouse model of multiple sclerosis. Komegae EN; Souza TA; Grund LZ; Lima C; Lopes-Ferreira M PLoS One; 2017; 12(2):e0171796. PubMed ID: 28235052 [TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors in multiple sclerosis mouse experimental models. Marta M Ann N Y Acad Sci; 2009 Sep; 1173():458-62. PubMed ID: 19758186 [TBL] [Abstract][Full Text] [Related]
17. Identification of new therapeutic targets for prevention of CNS inflammation. Owens T Expert Opin Ther Targets; 2002 Apr; 6(2):203-15. PubMed ID: 12223081 [TBL] [Abstract][Full Text] [Related]
18. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review. Aharoni R J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599 [TBL] [Abstract][Full Text] [Related]
19. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu. Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS Front Immunol; 2018; 9():1078. PubMed ID: 29892282 [TBL] [Abstract][Full Text] [Related]
20. ERβ in CD4+ T Cells Is Crucial for Ligand-Mediated Suppression of Central Nervous System Autoimmunity. Aggelakopoulou M; Kourepini E; Paschalidis N; Panoutsakopoulou V J Immunol; 2016 Jun; 196(12):4947-56. PubMed ID: 27183630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]